XML 41 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
BUSINESS COMBINATIONS BUSINESS COMBINATIONS
3 Months Ended
Sep. 30, 2013
Business Combinations [Abstract]  
BUSINESS COMBINATIONS
 
On July 1, 2013, the Company acquired ENTrigue Surgical, Inc. ("ENTrigue"), a privately-held Delaware corporation specializing in ENT sinus surgical products. The Company paid approximately $45.0 million in cash to the former stockholders of ENTrigue, less an amount placed in escrow to secure the indemnification obligations of the former stockholders of ENTrigue.

The Agreement also provides that the Company will make annual cash payments to the former stockholders of ENTrigue shortly after each of the next five anniversaries of the acquisition date based on the annual net sales of the acquired products. The annual payment shall equal annual net sales growth times the applicable sales growth multiple for the year. The sales growth multiple is 0.6 for years 1-3; 1.1 for year 4; and 1.25 for year 5. For purposes of calculating this multiple, the annual growth of net sales each year is determined by subtracting the highest amount of net sales in any previous year from the net sales in the current year. The range of undiscounted future payments that could be required is currently estimated to be between $2.4 million and $32.2 million. The estimated fair value of the contingent consideration arrangement used for determining total purchase price is $14.5 million, which was estimated by applying the income approach using a Monte Carlo simulation model. That measure is based on valuation inputs that are not observable in the market.

The purchase price was allocated to the assets acquired and liabilities assumed based on estimates of fair values at the date of acquisition and is summarized below (in thousands):

Current assets
$
2,201

Property, plant and equipment
340

Intangible assets
2,386

Goodwill
45,187

Deferred tax assets
10,093

     Total assets acquired
60,207

Liabilities
664

     Total purchase price
$
59,543

Cash payments at acquisition date
45,000

Fair value of contingent consideration liability
14,543

     Total purchase price
$
59,543



The fair value of the assets and liabilities acquired, including goodwill, is preliminary and therefore may be subject to adjustments. The goodwill of $45.2 million arising from the acquisition is not expected to be deductible for income tax purposes. Subsequent to July 1, 2013, the revenues and expenses of ENTrigue have been included in the Company's consolidated statements of income. The Company incurred transaction related expenses of approximately $0.8 million for the nine months ended September 30, 2013 which have been recorded as general and administrative expenses.

The fair value and weighted-average useful life of the identifiable intangible assets acquired are summarized below (in thousands):

 
 
 
 
Weighted-Average Useful Life
 
 
 
 
 
Trade names
 
$
410

 
9 Years
Developed technology
 
940

 
12 Years
Customer relationships
 
390

 
10 Years
Distribution agreements
 
280

 
3 Years
Non-compete agreements
 
366

 
5 Years
 
 
$
2,386

 
 

See further discussion of future amortization expense for intangible assets in Note 4.